ZIM Corporation (ZIMCF)
OTCMKTS · Delayed Price · Currency is USD
0.0002
0.00 (0.00%)
At close: Feb 17, 2026
ZIM Corporation Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
5
Market Cap
1.63K
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2021 | - | - | - |
| Mar 31, 2020 | - | - | - |
| Mar 31, 2019 | - | - | - |
| Mar 31, 2018 | 503.24K | -167.66K | -24.99% |
| Mar 31, 2017 | 670.90K | 51.61K | 8.33% |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2013 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2012 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| EV Biologics | 9.47M |
| Affimed | 6.29M |
| Alzex Neuropharma | 4.73M |
| DNAPrint Genomics | 1.93M |
| Trevena | 546.00K |
| Syros Pharmaceuticals | 386.00K |
| Aditxt | 14.34K |